Extracellular 5′-nucleotidase (CD73) promotes human breast cancer cells growth through AKT/GSK-3β/β-catenin/cyclinD1 signaling pathway

The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets

(2017) Bertrand Allard et al.   IMMUNOLOGICAL REVIEWS

Prognostic impact of CD73 and A2A adenosine receptor expression in non-small-cell lung cancer

(2017) Yusuke Inoue et al.   Oncotarget

Co-inhibition of CD73 and A2AR Adenosine Signaling Improves Anti-tumor Immune Responses

(2016) Arabella Young et al.   CANCER CELL

CD73 is associated with poor prognosis in HNSCC

(2016) Zhen-Hu Ren et al.   Oncotarget

Anti-CD73 immunotherapy: A viable way to reprogram the tumor microenvironment

(2016) Luca Antonioli et al.   OncoImmunology

Wnt/Catenin Signaling in Adult Stem Cell Physiology and Disease

(2014) Alexander Ring et al.   Stem Cell Reviews and Reports

Targeting Cancer-Derived Adenosine:New Therapeutic Approaches

(2014) A. Young et al.   Cancer Discovery

The Roles of CD73 in Cancer

(2014) Zhao-wei Gao et al.   Biomed Research International

A2Ablockade enhances anti-metastatic immune responses

(2014) Paul A Beavis et al.   OncoImmunology

Potential Targets for Prevention of Colorectal Cancer: a Focus on PI3K/Akt/mTOR and Wnt Pathways

(2013) Ashok Kumar Pandurangan   Asian Pacific Journal of Cancer Prevention

Wnt/β-catenin signalling: from plasma membrane to nucleus

(2013) Wantae Kim et al.   BIOCHEMICAL JOURNAL

Ecto-5′-nucleotidase (CD73) promotes tumor angiogenesis

(2013) Li Wang et al.   CLINICAL & EXPERIMENTAL METASTASIS

Novel Approaches for Molecular Targeted Therapy of Breast Cancer: Interfering with PI3K/AKT/mTOR Signaling

(2013) Thomas W. Grunt et al.   CURRENT CANCER DRUG TARGETS

Anti-Human CD73 Monoclonal Antibody Inhibits Metastasis Formation in Human Breast Cancer by Inducing Clustering and Internalization of CD73 Expressed on the Surface of Cancer Cells

(2013) M. G. Terp et al.   JOURNAL OF IMMUNOLOGY

CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer

(2013) S. Loi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Blockade of A2Areceptors potently suppresses the metastasis of CD73+tumors

(2013) Paul A. Beavis et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

NT5E (CD73) is epigenetically regulated in malignant melanoma and associated with metastatic site specificity

(2012) H Wang et al.   BRITISH JOURNAL OF CANCER

CD73 and adenosine generation in the creation of regulatory microenvironments

(2012) F. S. Regateiro et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Potential prognostic biomarker CD73 regulates epidermal growth factor receptor expression in human breast cancer

(2012) Xiuling Zhi et al.   IUBMB LIFE

High expression of CD73 as a poor prognostic biomarker in human colorectal cancer

(2012) Xian-Rui Wu et al.   JOURNAL OF SURGICAL ONCOLOGY

Crystal Structure of the Human Ecto-5′-Nucleotidase (CD73): Insights into the Regulation of Purinergic Signaling

(2012) Karen Knapp et al.   STRUCTURE

CD73 promotes tumor growth and metastasis

(2012) Bin Zhang   OncoImmunology

The wnt/β-catenin signaling pathway: A potential therapeutic target in the treatment of triple negative breast cancer

(2011) Taj D. King et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Adenosine induces cell-cycle arrest and apoptosis in androgen-dependent and -independent prostate cancer cell lines, LNcap-FGC-10, DU-145, and PC3

(2011) Mahmoud Aghaei et al.   PROSTATE

CD73 Expression as a Potential Marker of Good Prognosis in Breast Carcinoma

(2011) Anna Supernat et al.   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY

Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis

(2010) J. Stagg et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Phosphatidylinositol 3-Kinase γ Is a Critical Mediator of Myocardial Ischemic and Adenosine-Mediated Preconditioning

(2008) Kiwon Ban et al.   CIRCULATION RESEARCH